Clinical Trials Browser

Phase 2 × OKN 007 × Clear all

NCT04388475 2025-08-12

Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma

Phase 2 Completed

Glioma